Navigation Links
InterMune Reports Second Quarter 2008 Financial Results and Business Highlights
Date:7/31/2008

of its $170 million of

outstanding convertible notes with certain existing debt holders.

As a result, the amount of outstanding convertible notes is

unchanged, but now consists of two tranches: $85 million of 0.25%

convertible notes due 2011 and $85 million of 5.00% convertible

notes due 2015.

-- Holders of the 2011 notes may convert those notes at a conversion

price of approximately $21.63 per share. Holders of the 2015 notes

may convert their notes into shares of InterMune common stock at a

conversion price of approximately $18.88 per share, which is subject

to decrease in certain circumstances.

-- The debt restructuring effectively extended the maturity date of $85

million of InterMune's total $170 million of outstanding convertible

notes by four years with relatively modest dilution.

For additional information regarding InterMune's debt exchange, please refer to InterMune's Reports on Form 8-K filed on June 10, 2008 and June 24, 2008.

Guidance for 2008 Operating Expenses

InterMune today reiterated its guidance with respect to operating expenses in 2008.

For the year ending December 31, 2008, R&D expense is anticipated to be in a range of approximately $100 to $110 million, net of development cost reimbursements under the Roche collaboration. G&A expense is anticipated to be in a range of approximately $25 to $30 million.

Key Development Program Milestones - Next Six Months

InterMune today noted the upcoming milestones expected during the next six months on its key development programs.

CAPACITY Program in IPF:

-- InterMune expects to announce top-line results of its Phase 3

CAPACITY program in IPF in January of 2009.

-- If Shionogi's jNDA is approved, Shionogi has announced that it would

launch pirfenidone in Japan i
'/>"/>

SOURCE InterMune, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. InterMune to Present at Thomas Weisel and Bear Stearns Healthcare Conferences
2. InterMune Announces Proposed Public Offering of Common Stock
3. InterMune Announces Pricing of $68 Million Public Offering of Common Stock
4. InterMune Announces Closing of Public Offering of Common Stock
5. InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance
6. InterMune to Present at the SIGnificant Options in Healthcare Conference
7. Evotec Expands Collaboration With InterMune
8. Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct
9. InterMune to Present at Deutsche Bank Health Care Conference
10. InterMune to Present at Bank of America Health Care Conference
11. InterMune to Present at Citigroup Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... DIEGO , May 5, 2015  A group ... formation of the Coma Research Institute, a non-profit organization ... patients and families suffering from disorders of consciousness.  ... - http://photos.prnewswire.com/prnh/20150504/213779LOGO   ... disorder of consciousness, in which no voluntary actions can ...
(Date:5/5/2015)... Franz Inc ., the leading supplier of Semantic ... AllegroGraph, has been named a Champion by Bloor Research in ... AllegroGraph is a high performance Semantic Graph Database that enables ... skyrocketing in popularity and have grown by 400% in the ... by DB-Engines. , “We are excited that Graph and ...
(Date:5/5/2015)... , May 05, 2015 Research and ... the addition of the "Clinical Laboratory, Molecular ... Forecasts 2015 to 2019 - Europe Version" ... developments especially in the area of molecular diagnostics ... growing and evolving world market that is moving ...
(Date:5/5/2015)... May 5, 2015  Orexigen Therapeutics, Inc. (Nasdaq: ... quarter 2015 on Friday, May 8 before the market ... webcast and conference call at 8:30 a.m. Eastern Time ... may be accessed by phone by calling (800) 708-4540 ... webcast can be accessed live on the Investors section ...
Breaking Biology Technology:Biotechnology Executives and Medical Doctors Team Up to Tackle Coma and Disorders of Consciousness 2Biotechnology Executives and Medical Doctors Team Up to Tackle Coma and Disorders of Consciousness 3Biotechnology Executives and Medical Doctors Team Up to Tackle Coma and Disorders of Consciousness 4Biotechnology Executives and Medical Doctors Team Up to Tackle Coma and Disorders of Consciousness 5Bloor Research Positions AllegroGraph as a ‘Champion’ in Burgeoning Graph Database Market 2Bloor Research Positions AllegroGraph as a ‘Champion’ in Burgeoning Graph Database Market 3European Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market 2015-2019 2
... , - Books Authored by ... Two of the biggest names in health care publishing, ... agreement to,co-publish International Classification of Diseases, Ninth Revision, Clinical,Modification (ICD-9-CM) ... Buck, beginning with the 2010 editions, in fall 2009. , ...
... Viroblock SA has announced,today that the first ... is active against human influenza. Viroblock,s patented,Cholesterol ... during the extra-cellular phase, by altering and ... The two pre-clinical studies exposed ferrets ...
... Md., March 31 ImQuest Life Sciences today ... of the pyrimidinedione small molecules as antiviral agents ... and Liver Disease meeting held last week in ... ten pyrimidinediones as inhibitors of HBV replication, with ...
Cached Biology Technology:The American Medical Association and Elsevier Join to Co-Publish ICD-9-CM and HCPCS Coding Reference Books 2The American Medical Association and Elsevier Join to Co-Publish ICD-9-CM and HCPCS Coding Reference Books 3Viroblock SA Reports Positive Results of Preclinical Studies in Antiviral Nasal Spray 2ImQuest Presents Data on the Anti-Hepatitis B Virus Activity of Pyrimidinediones at the 13th ISVHLD Meeting in Washington D.C. 2
(Date:4/27/2015)... , April 27, 2015  For more than four ... show has been the premier worldwide event for the ... is a must-attend event for any local, national, or ... the emerging commercial markets and current applications of unmanned ... of this projected $48 billion industry, and how it ...
(Date:4/27/2015)... , Apr. 27, 2015 Profile Solutions, ... control and security systems is pleased to announce that ... as a consultant and member of its scientific advisory ... widely known as a thought leader in technology-enhanced learning ... Technology Group, and has published studies and books focused ...
(Date:4/20/2015)... 2015 Huntington Memorial Hospital is the first ... new miniaturized, wireless monitoring sensor to manage heart failure ... only FDA-approved heart failure monitoring device that has been ... physicians to manage heart failure. The CardioMEMS ... the pulmonary artery (PA) during a non-surgical procedure to ...
Breaking Biology News(10 mins):UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3
... Jan. 24, 2011 More than a dozen University ... from robot-assisted surgery techniques to improving heart and breast ... computational surgery Jan. 26-28. The symposium will be held ... Held at the Methodist Institute for ...
... will host its 2011 Biodefense and Emerging Diseases Research ... Hotel in Washington, DC. The purpose of this ... out research to defend against the threat of bioterrorism ... recognizing that emerging infectious diseases serve as a paradigm ...
... important in any relationship, but for spiders, it can be ... male spider needs to convince potentially cannibalistic females that he ... research from the University of Cincinnati shows that male wolf ... increasing their opportunities to successfully mate. To improve the ...
Cached Biology News:Forum to focus on using robotics, imaging and simulation in surgeries 2Forum to focus on using robotics, imaging and simulation in surgeries 3Spiders adjust courtship signals for maximum effect 2Spiders adjust courtship signals for maximum effect 3
Human DEP-1/CD148 Fluorescein MAb (Clone 143-41) Protein Family: Granulocyte Markers, Monocyte Markers, Phosphatases & Regulators, Other Dendritic Cell Molecules...
MOUSE ANTI PORCINE SLA 1:FITC Immunogen: Porcine peripheral blood mononuclear cells....
NNT-1/BSF-3 (N-14)...
Monoclonal 8C2.1 is specific for Bunyavirus G1 as tested by neutralization, immunoprecipitation and immunobinding assays....
Biology Products: